Methods of preventing and reducing the severity of stress-associated conditions
US7977335B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | May 2, 2008 |
| Grant date | Jul 12, 2011 |
| Priority date | — |
| Expiry date | May 2, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a method of preventing or reducing the severity of a stress-associated condition in a subject by systemically administering to the subject an effective amount of brimonidine or a pharmaceutically acceptable salt, ester, amide, stereoisomer or racemic mixture thereof. Stress-associated conditions that can be treated according to a method of the invention include, but are not limited to, dyspepsia, tachycardias other than tachycardia associated with myocardial ischemia, panic attack, non-inflammatory dermatological conditions, disorders of muscle contraction, sensory hypersensitivity associated with migraine, and behavioral disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.